Tyrosine Kinase Inhibitors and Proton Pump Inhibitors: An Evaluation of Treatment Options

Tyrosine kinase inhibitors (TKIs) have rapidly become an established factor in oncology, and have been shown to be effective in a wide variety of solid and hematologic malignancies. Use of the oral administration route of TKIs offers flexibility and is convenient for the patient; however, despite th...

Descripción completa

Detalles Bibliográficos
Autores principales: van Leeuwen, Roelof W. F., Jansman, Frank G. A., Hunfeld, Nicole G., Peric, Robert, Reyners, Anna K. L., Imholz, Alex L. T., Brouwers, Jacobus R. B. J., Aerts, Joachim G., van Gelder, Teun, Mathijssen, Ron H. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Current Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488129/
https://www.ncbi.nlm.nih.gov/pubmed/28101705
http://dx.doi.org/10.1007/s40262-016-0503-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488129/
https://www.ncbi.nlm.nih.gov/pubmed/28101705
http://dx.doi.org/10.1007/s40262-016-0503-3

Ejemplares similares